pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Sep 23·1 min read
save

Former Changsheng biotech chair sentenced to life in prison over Chinese rabies vaccine scandal

Sep 23, 2026·read at Endpoints ↗RegulatoryNegative

Chinese authorities sentenced Gao Junfang, the former chairwoman of Changsheng Biotechnology, to life imprisonment after a court found her guilty of wrongdoing in a rabies vaccine scandal.

The case highlighted alleged falsification of data and lapses in manufacturing that raised concerns about vaccine safety in China.

In separate industry news, defense contractor Flagship announced it had won a new defense contract, while brief updates were noted about Caliway and Bristol Myers Squibb.

The harsh sentence signals heightened regulatory enforcement in the Chinese biotech sector and may weigh on investor sentiment.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Chinese vaccine scandal leads to life sentence; Flagship wins defense contract”

read at Endpoints ↗
80 words · retrieved Sep 23
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
BRISTOL2BRISTOL MYERS SQUIBB2BRISTOL MYERS SQUIBB CO2
drugs
rabies vaccine2
topics
Vaccine5

related stories

  • 1d agoImmutep, Molecular cut workforcesBioSpace
  • Oct 23STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billionSTAT
  • Oct 22Critical decisions that spurred these 40 Under 40 winners to successBioSpace
  • Oct 21Disc’s redemption, China’s rise, Veradermics’ validation, ESMO’s headlinersBioSpace
  • Oct 13BioNTech mRNA cancer immunotherapy misses first objective in key studyBioPharma Dive